[Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma]
{{output}}
Objective: To evaluate the efficacy and safety of Bruton tyrosine kinase inhibitor (BTKi) combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma (DE-DLBCL) . Methods: A retrospective analysis was conducted on 95 patients... ...
